C Bokemeyer
Overview
Explore the profile of C Bokemeyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
333
Citations
4856
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schmidt B, Afflerbach A, Ludewig P, Dirksen P, Paulsen F, Magnus T, et al.
ESMO Open
. 2024 Oct;
9(11):103974.
PMID: 39471564
No abstract available.
2.
Secondino S, Badoglio M, Rosti G, Labopin M, Delaye M, Bokemeyer C, et al.
ESMO Open
. 2024 Sep;
9(9):103692.
PMID: 39241498
Background: Primary mediastinal germ-cell tumors (PMGCTs) account for 1%-3% of all germ-cell tumors (GCTs). Non-seminoma have a poorer prognosis compared to their gonadal counterpart and, according to the International Germ...
3.
Seidel C, Schaefers C, Connolly E, Weickhardt A, Grimison P, Wong V, et al.
ESMO Open
. 2024 May;
9(5):103449.
PMID: 38744098
Background: In relapsed or refractory (RR) metastatic germ cell cancer (GCC), high-dose (HD) chemotherapy (CTX) plus autologous stem cell transplantation is considered the standard of care. Limited data exist regarding...
4.
Karapetis C, Liu H, Sorich M, Pederson L, Van Cutsem E, Maughan T, et al.
Br J Cancer
. 2024 Feb;
130(8):1269-1278.
PMID: 38402342
Background: KRAS mutations in metastatic colorectal cancer (mCRC) are used as predictive biomarkers to select therapy with EGFR monoclonal antibodies (mAbs). Other factors may be significant determinants of benefit. Methods:...
5.
Illert A, Stenzinger A, Bitzer M, Horak P, Gaidzik V, Moller Y, et al.
Nat Med
. 2023 Jun;
29(6):1298-1301.
PMID: 37280276
No abstract available.
6.
Schaefers C, Paulsen F, Frenzel C, Weisel K, Bokemeyer C, Seidel C
Br J Haematol
. 2023 Feb;
201(2):222-226.
PMID: 36793157
Immune thrombocytopenia (ITP) was reported as a rare complication of COVID-19 vaccines. We conducted a retrospective single-center analysis of all ITP cases detected in 2021 and compared the quantity with...
7.
Harnischfeger N, Rath H, Alt-Epping B, Brand H, Haller K, Letsch A, et al.
ESMO Open
. 2022 Nov;
7(6):100623.
PMID: 36356411
Introduction: In advanced cancer care, early communication about palliative care (PC) and end-of-life (EoL)-related issues is recommended, but is often impeded by physicians' communication insecurities. We investigated the effect of...
8.
Strangl F, Ischanow E, Ullrich A, Oechsle K, Fluschnik N, Magnussen C, et al.
Clin Res Cardiol
. 2022 Apr;
112(1):49-58.
PMID: 35420358
Background: Beyond guideline-directed treatments aimed at improving cardiac function and prognosis in heart failure (HF), patient-reported outcomes have gained attention. Purpose: Using a cross-sectional approach, we assessed symptom burden, psychosocial...
9.
Janning M, Suptitz J, Albers-Leischner C, Delpy P, Tufman A, Velthaus-Rusik J, et al.
Ann Oncol
. 2022 Mar;
33(6):602-615.
PMID: 35263633
Background: Atypical EGFR mutations occur in 10%-30% of non-small-cell lung cancer (NSCLC) patients with EGFR mutations and their sensitivity to classical epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKI) is...
10.
Oldenburg J, Berney D, Bokemeyer C, Climent M, Daugaard G, Gietema J, et al.
Ann Oncol
. 2022 Jan;
33(4):362-375.
PMID: 35065204
No abstract available.